Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, Bio-Rad Settle on Lawsuit Claiming Patent Infringement of SPR Technology

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare today it has settled with Bio-Rad Laboratories over litigation related to GE Healthcare Life Sciences' technology for studying molecular interactions with surface plasmon resonance.

Financial terms of the settlement were not disclosed. In 2010 GE Healthcare sued Bio-Rad in Germany alleging infringement of SPR-related patents.

GE Healthcare said that it and Bio-Rad have withdrawn their claims and GE Healthcare has granted a license to Bio-Rad to a collection of patents, which relate to certain aspects of GE Healthcare's technology and Biacore instrument for SPR-based quantitative studies of molecular interactions.

The non-exclusive license gives Bio-Rad rights to use GE Healthcare's technologies in Bio-Rad's SPR products.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.